Abstract:Guidelines recommend Menopausal Hormone Therapy (MHT) as the most effective treatment for menopausal symptoms. However, a local study found that the usage of MHT among menopausal women was low (8.1%), with one of the main reasons being it is not recommended by doctors. Therefore, the objectives of this study are to determine the prevalence of offering MHT in treating symptomatic menopausal women among primary care doctors (PCDs) and its associated factors. This cross-sectional study involved PCDs from the Federal Territory of Kuala Lumpur, the Federal Territory of Putrajaya and the state of Selangor. All PCDs provided services in government primary care clinics from the three states were invited through the doctor in charge of each clinic. An online survey links was provided for the participants to the self-administered questionnaire. The questionnaire included PCDs' demographics, their menopause management practices, attitudes towards MHT, perceived barriers in offering MHT, knowledge of related guidelines and received training on menopause management. The outcome variable was offering MHT which defined as either prescription of MHT or referral to hospital for MHT initiation. Multivariate logistic regression analysis was performed to determine the factors associated with offering MHT. The response rate was 42.9% (559/1301). Of those who participated in the study, 77.8% of PCDs were female and 89.1% were medical officer. Although 66.9% of the participants reported offering MHT to their patients, the actual prescription rate was low (0.9%). Most PCDs (66%) would refer the patients to hospitals. 87.1% of PCDs (487/559) reported that MHT was not available in their clinic. In the past 12 months, 83% of PCDs had not received any related training. Female PCDs (AOR:2.5, CI: 1.51–4.13, p<0.001), perceiving MHT as preference treatment for menopause symptom (AOR:3.6, CI: 2.13–6.19, p < 0.001), having likelihood to recommend MHT to family and friends (AOR:3.0, CI: 1.87–4.83, p < 0.001), and receiving training on menopause management (AOR:2.7, CI: 1.30–5.56, p = 0.008) were the positive predictor of offering MHT. The negative predictors in offering MHT were no-experience in prescribing MHT (AOR: 0.4, CI: 0.15–0.87, p = 0.024) and lack of information regarding MHT for the patient (AOR: 0.4, CI:0.20–0.67, p < 0.001). The study revealed a low rate of MHT prescription among PCDs, with many relying on referrals to hospitals for managing menopausal symptoms. The findings underscore the need for strategies that includes fulfilling professional training gaps, improving MHT availability, and improving information dissemination for patient.

Knowledge and Awareness Toward Menopausal Hormone Therapy in a Fourth-Tier City of China

Assessment of knowledge, understanding and awareness of Chinese women clinical staff towards menopause hormone therapy: a survey study

Exploring menopausal symptoms, attitudes, and behaviors among menopausal women in China: an online research perspective

Knowledge and Attitude Towards Menopause and Hormone Replacement Therapy in Chinese Women.

Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey.

Investigation on Awareness of Perimenopausal Hormone Replacement Therapy

Survey of knowledge about menopause by medical staff

Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study

Exploring hormone replacement therapy dynamics among menopausal women in Kuala Lumpur - a community based survey

The use and discontinuation of hormone replacement therapy in women in South China

Low-dose hormone therapy in postmenopausal women in China

Prevalence of offering menopause hormone therapy among primary care doctors and its associated factors: A cross-sectional study

[Survey on Characteristics of Menopause of Chinese Women with the Age of 40-60 Years at Gynecological Clinic from 14 Hospitals].

Perimenopausal Clinical Performance As Well As Cognition and Demand for Knowledge of Perimenopause in Community-Dwelling Women

Demands for perimenopausal health care in women aged 40 to 60 years-a hospital-based cross-sectional study in Shanghai, China.

The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries

Symptoms, health behavior and understanding of menopause therapy in women with premature menopause

The evolving perspective of menopause management in the United Kingdom

Awareness and Knowledge of Women About Hormone Replacement Therapy in Taif City, Saudi Arabia

A classic chinese medicinal formula in relieving menopausal symptoms : a multi-centre and controlled trial from uk and china

Zhi-Bai-Di-Huang-Wan, A Classic Chinese Medicinal Formula in Relieving Menopausal Symptoms: A Multi-Centre and Controlled Trial from Uk and China